United States Polio Vaccine Market Report 2017

December 2017 | 110 pages | ID: U41405C5C55EN
QYResearch

Abstracts

In this report, the United States Polio Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Polio Vaccine in these regions, from 2012 to 2022 (forecast).

United States Polio Vaccine market competition by top manufacturers/players, with Polio Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Bibcol
• Sanofi
• Merck & Co
• Pfizer
• Beijing Tiantan Biological
• Bio-Med
• Panacea Biotec Ltd
• Adithya Vaccine Pharma
• Sinovac Biotech Ltd
• IPOL
• Halfkin Bio-Pharmaceuticals Corporation Ltd
• Aventis Pasteur

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Type
• Inactivated Polio Vaccine (IPV)
• Oral Polio Vaccine (OPV)
• By Type 2
• Live Attenuated Vaccine
• Inactivated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinics
• Public Services
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Polio Vaccine Market Report 2017

1 POLIO VACCINE OVERVIEW

1.1 Product Overview and Scope of Polio Vaccine
1.2 Classification of Polio Vaccine by Product Category
  1.2.1 United States Polio Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Polio Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Inactivated Polio Vaccine (IPV)
  1.2.4 Oral Polio Vaccine (OPV)
1.3 United States Polio Vaccine Market by Application/End Users
  1.3.1 United States Polio Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Public Services
  1.3.5 Others
1.4 United States Polio Vaccine Market by Region
  1.4.1 United States Polio Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Polio Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Polio Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Polio Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Polio Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Polio Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Polio Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Polio Vaccine (2012-2022)
  1.5.1 United States Polio Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Polio Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES POLIO VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Polio Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Polio Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Polio Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Polio Vaccine Market Competitive Situation and Trends
  2.4.1 United States Polio Vaccine Market Concentration Rate
  2.4.2 United States Polio Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES POLIO VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Polio Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Polio Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Polio Vaccine Price by Region (2012-2017)

4 UNITED STATES POLIO VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Polio Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Polio Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Polio Vaccine Price by Type (2012-2017)
4.4 United States Polio Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES POLIO VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Polio Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Polio Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES POLIO VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Polio Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bibcol
  6.2.2 Polio Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Polio Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co
  6.4.2 Polio Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.2 Polio Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Beijing Tiantan Biological
  6.6.2 Polio Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Beijing Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bio-Med
  6.7.2 Polio Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Panacea Biotec Ltd
  6.8.2 Polio Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Adithya Vaccine Pharma
  6.9.2 Polio Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Adithya Vaccine Pharma Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sinovac Biotech Ltd
  6.10.2 Polio Vaccine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sinovac Biotech Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 IPOL
6.12 Halfkin Bio-Pharmaceuticals Corporation Ltd
6.13 Aventis Pasteur

7 POLIO VACCINE MANUFACTURING COST ANALYSIS

7.1 Polio Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Polio Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Polio Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Polio Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES POLIO VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Polio Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Polio Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Polio Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Polio Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Polio Vaccine
Figure United States Polio Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Polio Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated Polio Vaccine (IPV) Product Picture
Figure Oral Polio Vaccine (OPV) Product Picture
Figure United States Polio Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Polio Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Public Services Examples
Table Key Downstream Customer in Public Services
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Polio Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Polio Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Polio Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Polio Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Polio Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Polio Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Polio Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Polio Vaccine Sales Share by Players/Suppliers
Figure United States Polio Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Polio Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Polio Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Polio Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Polio Vaccine Revenue Share by Players/Suppliers
Table United States Market Polio Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Polio Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Polio Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Polio Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Polio Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Polio Vaccine Product Category
Table United States Polio Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Polio Vaccine Sales Share by Region (2012-2017)
Figure United States Polio Vaccine Sales Share by Region (2012-2017)
Figure United States Polio Vaccine Sales Market Share by Region in 2016
Table United States Polio Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Polio Vaccine Revenue Share by Region (2012-2017)
Figure United States Polio Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Polio Vaccine Revenue Market Share by Region in 2016
Table United States Polio Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Polio Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Polio Vaccine Sales Share by Type (2012-2017)
Figure United States Polio Vaccine Sales Share by Type (2012-2017)
Figure United States Polio Vaccine Sales Market Share by Type in 2016
Table United States Polio Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Polio Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polio Vaccine by Type (2012-2017)
Figure Revenue Market Share of Polio Vaccine by Type in 2016
Table United States Polio Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Polio Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Polio Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Polio Vaccine Sales Market Share by Application (2012-2017)
Figure United States Polio Vaccine Sales Market Share by Application (2012-2017)
Figure United States Polio Vaccine Sales Market Share by Application in 2016
Table United States Polio Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Polio Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Polio Vaccine Sales Growth Rate (2012-2017)
Figure GSK Polio Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Bibcol Basic Information List
Table Bibcol Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bibcol Polio Vaccine Sales Growth Rate (2012-2017)
Figure Bibcol Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Bibcol Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Polio Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co Polio Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Merck & Co Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Polio Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Pfizer Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Beijing Tiantan Biological Basic Information List
Table Beijing Tiantan Biological Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Beijing Tiantan Biological Polio Vaccine Sales Growth Rate (2012-2017)
Figure Beijing Tiantan Biological Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Beijing Tiantan Biological Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Bio-Med Basic Information List
Table Bio-Med Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Med Polio Vaccine Sales Growth Rate (2012-2017)
Figure Bio-Med Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Bio-Med Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Panacea Biotec Ltd Basic Information List
Table Panacea Biotec Ltd Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Panacea Biotec Ltd Polio Vaccine Sales Growth Rate (2012-2017)
Figure Panacea Biotec Ltd Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Panacea Biotec Ltd Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Adithya Vaccine Pharma Basic Information List
Table Adithya Vaccine Pharma Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Adithya Vaccine Pharma Polio Vaccine Sales Growth Rate (2012-2017)
Figure Adithya Vaccine Pharma Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Adithya Vaccine Pharma Polio Vaccine Revenue Market Share in United States (2012-2017)
Table Sinovac Biotech Ltd Basic Information List
Table Sinovac Biotech Ltd Polio Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sinovac Biotech Ltd Polio Vaccine Sales Growth Rate (2012-2017)
Figure Sinovac Biotech Ltd Polio Vaccine Sales Market Share in United States (2012-2017)
Figure Sinovac Biotech Ltd Polio Vaccine Revenue Market Share in United States (2012-2017)
Table IPOL Basic Information List
Table Halfkin Bio-Pharmaceuticals Corporation Ltd Basic Information List
Table Aventis Pasteur Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polio Vaccine
Figure Manufacturing Process Analysis of Polio Vaccine
Figure Polio Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Polio Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Polio Vaccine
Table Distributors/Traders List
Figure United States Polio Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Polio Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Polio Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Polio Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Polio Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Polio Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Polio Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Polio Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Polio Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Polio Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Polio Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Polio Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Polio Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources